Opus Genetics, Inc. (IRD)

Data as of Oct 2, 2026, from SEC Form 4 filings.

XNASPHARMACEUTICAL PREPARATIONSNet insider selling (90d)Watch IRD

See up to 3 months of IRD. The 7-day demo opens the 1M and 3M ranges and puts IRD on your watchlist.

Latest IRD insider trades

Foundation Fighting Blindness Retinal Degeneration Fund - Director
Open-market sale$2.76M
Sep 30, 2026
Robert E. Gagnon - Officer
Open-market sale$127K
Sep 3, 2026
Benjamin R. Yerxa - Officer
Open-market sale$22K
Jul 23, 2026
Joseph K. Schachle - Officer
Open-market sale$14K
Jul 23, 2026
George Magrath - Officer
Open-market sale$28K
Jul 23, 2026
Robert E. Gagnon - Officer
Open-market sale$23K
Jul 23, 2026
Foundation Fighting Blindness Retinal Degeneration Fund - Director
Open-market sale$7.39M
May 18, 2026
Benjamin R. Yerxa - Officer
Open-market sale$39K
Apr 23, 2026

Follow insider buying without reading every filing

We read every Form 4 as it is filed, IRD's included, and rank the insider purchases worth a look into a daily trading plan.

Free by email: highlights from the previous session's daily trading plan each market morning, plus a Friday roundup of the week's insider buying.

Basic reads each plan from the previous close, before the open. Compare plans or see the daily plan.

IRD key statistics

Market cap: $352.75M
Average volume: 2.38M
52 week high: $7.07
52 week low: $1.70
Shares outstanding: 83.20M

Filings (90d)

Form 4

Purchases (90d)

Sales (90d)

$2.97M

Market cap

$352.75M

28 employees

IRD insider sentiment, last 90 days

How the dollar value of insider trades on Form 4 split between purchases and sales.

0% Buying100% Selling

6 insider sales totaling $2.97M and no purchases.

Most active IRD insiders in the last 90 days

About Opus Genetics, Inc. (IRD)

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Headquarters: DURHAM, NC
Employees: 28
Listed: 2020
Exchange: XNAS
Sector: Health Care

https://www.opusgtx.com SEC filings for IRD on EDGAR

IRD Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	6	613,331	$2.97M
Option exercise	4	2,352,942
Tax withholding / forfeiture	1	75,541

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

IRD insider transactions (Form 4)

62 Form 4 filings on record, the earliest from Oct 24, 2024, newest first. Filing history page 1 of 3.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 30, 2026	Foundation Fighting Blindness Retinal Degeneration Fund - Director	Open-market sale	Common Stock	556,000	$4.96^{footnote F1}	$2.76M
Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full… Full note on SEC EDGAR
Sep 9, 2026	George Magrath - Officer	Option exercise	Common Stock	392,157	$1.15	$451K
Sep 9, 2026	George Magrath - Officer	Tax withholding / forfeiture	Common Stock	75,541	$5.97	$451K
Sep 9, 2026	George Magrath - Officer	Option exercise	Warrant (right to buy)	392,157	$0.00	-
Sep 8, 2026	Cam Gallagher - Director	Option exercise	Common Stock	784,314	$1.15	$902K
Sep 8, 2026	Cam Gallagher - Director	Option exercise	Warrant (right to buy)	784,314	$0.00	-
Sep 3, 2026	Robert E. Gagnon - Officer	Open-market sale	Common Stock	28,000	$4.54^{footnote F2}	$127K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $4.29 to $4.79, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
Jul 23, 2026	Benjamin R. Yerxa - Officer	Open-market sale	Common Stock	7,429	$2.97	$22K
Jul 23, 2026	Joseph K. Schachle - Officer	Open-market sale	Common Stock	4,644	$2.94	$14K
Jul 23, 2026	George Magrath - Officer	Open-market sale	Common Stock	9,475	$2.95^{footnote F2}	$28K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9009 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
Jul 23, 2026	Robert E. Gagnon - Officer	Open-market sale	Common Stock	7,783	$2.95^{footnote F2}	$23K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9006 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
May 18, 2026	Foundation Fighting Blindness Retinal Degeneration Fund - Director	Open-market sale	Common Stock	1,700,000	$4.35	$7.39M
Apr 23, 2026	Benjamin R. Yerxa - Officer	Open-market sale	Common Stock	7,470	$5.24^{footnote F2}	$39K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2314 to $5.2413, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR
Apr 23, 2026	Joseph K. Schachle - Officer	Open-market sale	Common Stock	4,697	$5.22	$25K
Apr 23, 2026	Rabourn Amy Zaremba - Officer	Open-market sale	Common Stock	1,641	$5.20^{footnote F2}	$9K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR
Apr 23, 2026	George Magrath - Officer	Open-market sale	Common Stock	9,511	$5.22	$50K
Apr 23, 2026	Ashwath Jayagopal - Officer	Open-market sale	Common Stock	7,542	$5.19^{footnote F2}	$39K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.18 to $5.21, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
Apr 23, 2026	Robert E. Gagnon - Officer	Open-market sale	Common Stock	7,842	$5.18^{footnote F2}	$41K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.1828 to $5.1901, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR
Apr 20, 2026	Richard J. Rodgers	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	James S. J. Manuso	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	Adrienne L. Graves	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	Cam Gallagher	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	Susan Benton	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	Jean Bennett	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Apr 20, 2026	Sean Ainsworth	Grant or award	Common Stock	24,367^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR
Mar 16, 2026	Joseph K. Schachle - Officer	Open-market sale	Common Stock	3,719	$5.25	$20K
Mar 16, 2026	Rabourn Amy Zaremba - Officer	Open-market sale	Common Stock	2,816	$5.25	$15K
Mar 16, 2026	George Magrath - Officer	Open-market sale	Common Stock	24,438	$5.21^{footnote F2}	$127K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.21 to $5.215, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
Mar 16, 2026	Ashwath Jayagopal - Officer	Open-market sale	Common Stock	3,719	$5.12^{footnote F2}	$19K
Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR
Feb 12, 2026	Ashwath Jayagopal - Officer	Tax withholding / forfeiture	Common Stock	5,313	$3.39	$18K
Jan 22, 2026	Benjamin R. Yerxa - Officer	Grant or award	Common Stock	400,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Jan 22, 2026	Joseph K. Schachle - Officer	Grant or award	Common Stock	250,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Jan 22, 2026	Rabourn Amy Zaremba - Officer	Grant or award	Common Stock	86,500^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.

Recent IRD Form 8-K filings

Read IRD company news

Sep 11, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Sep 9, 2026Item 7.01, 8.01, 9.01

Read the filing on SEC EDGAR

Aug 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 16, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Jun 16, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Recent IRD Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 3, 2026	Gagnon Robert E.	Officer	28,000	$125K	View on EDGAR
Jul 23, 2026	-	-	-	-	View on EDGAR
Jul 23, 2026	-	-	-	-	View on EDGAR

IRD insider trading FAQ

What is the latest insider trade for IRD?

Opus Genetics, Inc. (IRD) had 8 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for IRD runs to 62 Form 4 filings, the earliest from 2024-10-24. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying IRD stock?

No insider purchases of IRD were filed in the last 90 days. 6 purchases are on record for this company.

How many insiders are selling IRD stock?

6 insider sales of IRD were filed in the last 90 days, totaling $2.97M.

Where can I see IRD SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects IRD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 2, 2026 - Foundation Fighting Blindness Retinal Degeneration Fund view on EDGAR
Sep 11, 2026 - George Magrath view on EDGAR
Sep 8, 2026 - Cam Gallagher view on EDGAR
Sep 8, 2026 - Robert E. Gagnon view on EDGAR
Jul 27, 2026 - Benjamin R. Yerxa view on EDGAR
Jul 27, 2026 - Joseph K. Schachle view on EDGAR
Jul 27, 2026 - George Magrath view on EDGAR
Jul 27, 2026 - Robert E. Gagnon view on EDGAR
May 20, 2026 - Foundation Fighting Blindness Retinal Degeneration Fund view on EDGAR
Apr 27, 2026 - Benjamin R. Yerxa view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where IRD's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow IRD with a 7-day demo

IRD on your watchlist
Every IRD Form 4 filing on record
Up to 3 months of IRD price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

613,331

$2.97M

Option exercise

2,352,942

Tax withholding / forfeiture

75,541

Date

Insider

Transaction

Security

Price

Value

Sep 30, 2026

Foundation Fighting Blindness Retinal Degeneration Fund - Director

Open-market sale

Common Stock

556,000

$4.96^{footnote F1}

$2.76M

Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full… Full note on SEC EDGAR

Sep 9, 2026

George Magrath - Officer

Option exercise

Common Stock

392,157

$1.15

$451K

Sep 9, 2026

George Magrath - Officer

Tax withholding / forfeiture

Common Stock

75,541

$5.97

$451K

Sep 9, 2026

George Magrath - Officer

Option exercise

Warrant (right to buy)

392,157

$0.00

Sep 8, 2026

Cam Gallagher - Director

Option exercise

Common Stock

784,314

$1.15

$902K

Sep 8, 2026

Cam Gallagher - Director

Option exercise

Warrant (right to buy)

784,314

$0.00

Sep 3, 2026

Robert E. Gagnon - Officer

Open-market sale

Common Stock

28,000

$4.54^{footnote F2}

$127K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $4.29 to $4.79, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

Jul 23, 2026

Benjamin R. Yerxa - Officer

Open-market sale

Common Stock

7,429

$2.97

$22K

Jul 23, 2026

Joseph K. Schachle - Officer

Open-market sale

Common Stock

4,644

$2.94

$14K

Jul 23, 2026

George Magrath - Officer

Open-market sale

Common Stock

9,475

$2.95^{footnote F2}

$28K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9009 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

Jul 23, 2026

Robert E. Gagnon - Officer

Open-market sale

Common Stock

7,783

$2.95^{footnote F2}

$23K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9006 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

May 18, 2026

Foundation Fighting Blindness Retinal Degeneration Fund - Director

Open-market sale

Common Stock

1,700,000

$4.35

$7.39M

Apr 23, 2026

Benjamin R. Yerxa - Officer

Open-market sale

Common Stock

7,470

$5.24^{footnote F2}

$39K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2314 to $5.2413, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR

Apr 23, 2026

Joseph K. Schachle - Officer

Open-market sale

Common Stock

4,697

$5.22

$25K

Apr 23, 2026

Rabourn Amy Zaremba - Officer

Open-market sale

Common Stock

1,641

$5.20^{footnote F2}

$9K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR

Apr 23, 2026

George Magrath - Officer

Open-market sale

Common Stock

9,511

$5.22

$50K

Apr 23, 2026

Ashwath Jayagopal - Officer

Open-market sale

Common Stock

7,542

$5.19^{footnote F2}

$39K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.18 to $5.21, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

Apr 23, 2026

Robert E. Gagnon - Officer

Open-market sale

Common Stock

7,842

$5.18^{footnote F2}

$41K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.1828 to $5.1901, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the… Full note on SEC EDGAR

Apr 20, 2026

Richard J. Rodgers

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

James S. J. Manuso

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

Adrienne L. Graves

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

Cam Gallagher

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

Susan Benton

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

Jean Bennett

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Apr 20, 2026

Sean Ainsworth

Grant or award

Common Stock

24,367^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service… Full note on SEC EDGAR

Mar 16, 2026

Joseph K. Schachle - Officer

Open-market sale

Common Stock

3,719

$5.25

$20K

Mar 16, 2026

Rabourn Amy Zaremba - Officer

Open-market sale

Common Stock

2,816

$5.25

$15K

Mar 16, 2026

George Magrath - Officer

Open-market sale

Common Stock

24,438

$5.21^{footnote F2}

$127K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.21 to $5.215, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

Mar 16, 2026

Ashwath Jayagopal - Officer

Open-market sale

Common Stock

3,719

$5.12^{footnote F2}

$19K

Footnote F2 (price): The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities… Full note on SEC EDGAR

Feb 12, 2026

Ashwath Jayagopal - Officer

Tax withholding / forfeiture

Common Stock

5,313

$3.39

$18K

Jan 22, 2026

Benjamin R. Yerxa - Officer

Grant or award

Common Stock

400,000^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.

Jan 22, 2026

Joseph K. Schachle - Officer

Grant or award

Common Stock

250,000^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.

Jan 22, 2026

Rabourn Amy Zaremba - Officer

Grant or award

Common Stock

86,500^{footnote F1}

$0.00

Footnote F1 (shares): Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.

Filed

Filer

Relationship

Market value

Notice

Sep 3, 2026

Gagnon Robert E.

Officer

28,000

$125K

View on EDGAR

Jul 23, 2026

View on EDGAR

Jul 23, 2026

View on EDGAR